Michael J. LaBarre
Net Worth

Last updated:

What is Michael J. LaBarre net worth?

The estimated net worth of Dr. Michael J. LaBarre is at least $36,825,263 as of 16 Oct 2024. He owns shares worth $12,162,920 as insider, has earned $21,111,443 from insider trading and has received compensation worth at least $3,550,900 in Halozyme Therapeutics, Inc..

What is the salary of Michael J. LaBarre?

Dr. Michael J. LaBarre salary is $710,180 per year as Senior Vice President & Chief Technical Officer in Halozyme Therapeutics, Inc..

What stocks does Michael J. LaBarre currently own?

As insider, Dr. Michael J. LaBarre owns shares in one company:

Company Title Shares Price per share Total value
Halozyme Therapeutics, Inc. (HALO) Senior Vice President & Chief Technical Officer 173,756 $70 $12,162,920

What does Halozyme Therapeutics, Inc. do?

Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. Its flagship product is Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in subcutaneous urography and to improve resorption of radiopaque agents. The company also develops Perjeta; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; Centre for the AIDS Programme of Research in South Africa; and ViiV Healthcare Limited for small and large molecule targets for the treatment and prevention of HIV. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.

HALO logo
HALO
Halozyme Therapeutics, Inc.
$70

Michael J. LaBarre insider trading

Halozyme Therapeutics, Inc.

Dr. Michael J. LaBarre has made 56 insider trades between 2020-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 40,315 units of HALO stock on 1 Jul 2021. As of 16 Oct 2024 he still owns at least 173,756 units of HALO stock.

Transaction Date Security Shares Price per share Total value Source
Option
Option to Purchase Common Stock 10,000 $19.98 $199,800
Sale
Common Stock 10,000 $53.26 $532,590
Option
Common Stock 10,000 $19.98 $199,800
Option
Option to Purchase Common Stock 4,491 $19.98 $89,730
Option
Common Stock 5,509 $16.65 $91,725
Option
Option to Purchase Common Stock 5,509 $16.65 $91,725
Sale
Common Stock 77 $54.25 $4,177
Sale
Common Stock 9,923 $53.74 $533,292
Option
Common Stock 10,000 $16.65 $166,500
Option
Option to Purchase Common Stock 10,000 $16.65 $166,500
Sale
Common Stock 2,037 $62.58 $127,477
Sale
Common Stock 7,963 $61.89 $492,838
Option
Option to Purchase Common Stock 10,000 $16.65 $166,500
Sale
Common Stock 10,000 $62.88 $628,780
Option
Option to Purchase Common Stock 5,580 $18.41 $102,728
Option
Common Stock 5,580 $18.41 $102,728
Option
Common Stock 10,000 $16.65 $166,500
Sale
Common Stock 9,900 $61.74 $611,236
Sale
Common Stock 100 $62.34 $6,234
Option
Option to Purchase Common Stock 10,000 $16.65 $166,500
Option
Option to Purchase Common Stock 10,000 $16.65 $166,500
Sale
Common Stock 10,000 $61.06 $610,550
Option
Option to Purchase Common Stock 8,285 $16.65 $137,945
Sale
Common Stock 10,000 $55.12 $551,150
Option
Option to Purchase Common Stock 1,715 $8.11 $13,909
Option
Common Stock 1,715 $8.11 $13,909
Option
Common Stock 8,285 $16.65 $137,945
Sale
Common Stock 4,709 $54.46 $256,466
Option
Option to Purchase Common Stock 10,000 $8.11 $81,100
Option
Common Stock 10,000 $8.11 $81,100
Sale
Common Stock 5,291 $55.27 $292,407
Option
Option to Purchase Common Stock 10,000 $8.11 $81,100
Option
Common Stock 10,000 $8.11 $81,100
Sale
Common Stock 10,000 $49.43 $494,260
Option
Option to Purchase Common Stock 10,000 $8.11 $81,100
Option
Common Stock 10,000 $8.11 $81,100
Sale
Common Stock 10,000 $45.38 $453,840
Option
Option to Purchase Common Stock 10,000 $8.11 $81,100
Sale
Common Stock 10,000 $45.16 $451,640
Option
Common Stock 10,000 $8.11 $81,100
Sale
Common Stock 10,000 $38.49 $384,890
Option
Option to Purchase Common Stock 10,000 $8.11 $81,100
Option
Option to Purchase Common Stock 10,000 $8.11 $81,100
Sale
Common Stock 10,000 $38.35 $383,500
Option
Common Stock 292 $16.78 $4,900
Option
Common Stock 2,890 $8.11 $23,438
Option
Option to Purchase Common Stock 8,728 $14.43 $125,901
Option
Option to Purchase Common Stock 2,890 $8.11 $23,438
Option
Common Stock 8,436 $12.07 $101,823
Option
Option to Purchase Common Stock 6,449 $12.07 $77,839
Sale
Common Stock 10,000 $42.27 $422,730
Option
Common Stock 3,551 $8.11 $28,799
Option
Option to Purchase Common Stock 3,551 $8.11 $28,799
Option
Common Stock 6,449 $12.07 $77,839
Sale
Common Stock 10,000 $41.64 $416,370
Option
Option to Purchase Common Stock 10,000 $12.07 $120,700
Option
Common Stock 10,000 $12.07 $120,700
Sale
Common Stock 10,000 $39.55 $395,510
Option
Common Stock 7,471 $8.11 $60,590
Option
Option to Purchase Common Stock 7,471 $8.11 $60,590
Sale
Common Stock 10,000 $39.95 $399,460
Option
Restricted Stock Units 4,264 N/A N/A
Option
Common Stock 6,112 N/A N/A
Option
Restricted Stock Units 6,112 N/A N/A
Option
Common Stock 4,264 N/A N/A
Option
Common Stock 3,386 N/A N/A
Option
Restricted Stock Units 3,386 N/A N/A
Option
Restricted Stock Units 8,133 N/A N/A
Option
Common Stock 8,133 N/A N/A
Option
Common Stock 10,000 $12.07 $120,700
Option
Option to Purchase Common Stock 10,000 $12.07 $120,700
Sale
Common Stock 10,000 $36 $360,000
Option
Option to Purchase Common Stock 10,000 $12.07 $120,700
Option
Common Stock 10,000 $12.07 $120,700
Option
Option to Purchase Common Stock 10,000 $12.07 $120,700
Sale
Common Stock 10,000 $40.39 $403,940
Sale
Common Stock 9,357 $39.58 $370,303
Option
Common Stock 8,533 $13.81 $117,841
Option
Option to Purchase Common Stock 1,467 $12.07 $17,707
Option
Option to Purchase Common Stock 8,533 $13.81 $117,841
Sale
Common Stock 643 $40.47 $26,019
Sale
Common Stock 10,000 $39.79 $397,880
Option
Option to Purchase Common Stock 10,000 $13.81 $138,100
Option
Common Stock 10,000 $13.81 $138,100
Sale
Common Stock 1,708 $39.08 $66,747
Option
Common Stock 1,708 $16.78 $28,660
Option
Option to Purchase Common Stock 1,708 $16.78 $28,660
Option
Common Stock 8,292 $13.81 $114,513
Option
Option to Purchase Common Stock 8,292 $13.81 $114,513
Option
Common Stock 10,000 $19.98 $199,800
Option
Option to Purchase Common Stock 10,000 $19.98 $199,800
Sale
Common Stock 10,000 $36.52 $365,200
Option
Option to Purchase Common Stock 10,000 $19.98 $199,800
Sale
Common Stock 10,000 $39.1 $390,980
Option
Common Stock 10,000 $19.98 $199,800
Option
Common Stock 8,075 $19.98 $161,339
Option
Common Stock 1,925 $18.41 $35,439
Option
Option to Purchase Common Stock 1,925 $18.41 $35,439
Sale
Common Stock 8,075 $42.41 $342,437
Option
Option to Purchase Common Stock 8,075 $19.98 $161,339
Option
Common Stock 12,825 $13.26 $170,060
Option
Option to Purchase Common Stock 10,000 $18.41 $184,100
Option
Option to Purchase Common Stock 7,175 $13.81 $99,087
Option
Option to Purchase Common Stock 2,825 $8.11 $22,911
Option
Common Stock 7,175 $13.81 $99,087
Sale
Common Stock 10,000 $40.43 $404,300
Option
Common Stock 10,000 $18.41 $184,100
Option
Option to Purchase Common Stock 10,000 $18.41 $184,100
Sale
Common Stock 10,000 $36 $360,000
Sale
Common Stock 10,000 $36 $360,000
Option
Option to Purchase Common Stock 10,000 $18.41 $184,100
Option
Common Stock 10,000 $18.41 $184,100
Sale
Common Stock 2,984 $49.55 $147,854
Sale
Common Stock 7,016 $49.55 $347,629
Option
Restricted Stock Units 6,112 N/A N/A
Option
Common Stock 6,112 N/A N/A
Sale
Common Stock 2,878 $49.26 $141,770
Option
Restricted Stock Units 3,386 N/A N/A
Option
Common Stock 3,386 N/A N/A
Sale
Common Stock 10,000 $48.39 $483,940
Option
Common Stock 7,883 N/A N/A
Option
Restricted Stock Unit 7,883 N/A N/A
Option
Common Stock 8,133 N/A N/A
Option
Restricted Stock Units 8,133 N/A N/A
Sale
Common Stock 1,122 $50.93 $57,139
Sale
Common Stock 8,878 $50.4 $447,451
Sale
Common Stock 4,935 $58.67 $289,541
Sale
Common Stock 5,065 $58.66 $297,133
Sale
Common Stock 3,115 $54.14 $168,643
Sale
Common Stock 8 $54.61 $437
Sale
Common Stock 6,877 $54.12 $372,183
Option
Restricted Stock Units 3,386 N/A N/A
Option
Common Stock 3,386 N/A N/A
Option
Restricted Stock Units 7,883 N/A N/A
Option
Common Stock 5,771 N/A N/A
Option
Restricted Stock Units 5,771 N/A N/A
Option
Restricted Stock Units 8,133 N/A N/A
Option
Common Stock 7,883 N/A N/A
Option
Common Stock 8,133 N/A N/A
Option
Option to Purchase Common Stock 8,050 $13.1 $105,455
Option
Common Stock 8,050 $13.1 $105,455
Option
Common Stock 29,450 $13.1 $385,795
Sale
Common Stock 29,450 $39.93 $1,175,968
Option
Option to Purchase Common Stock 29,450 $13.1 $385,795
Option
Common Stock 14,685 N/A N/A
Option
Option to Purchase Common Stock 14,685 N/A N/A
Option
Option to Purchase Common Stock 40,315 $6.55 $264,063
Option
Common Stock 40,315 $6.55 $264,063
Sale
Common Stock 40,315 $6.55 $264,063
Option
Common Stock 11,311 $11.29 $127,701
Option
Option to Purchase Common Stock 11,311 $11.29 $127,701
Option
Common Stock 28,689 $11.29 $323,899
Sale
Common Stock 28,689 $42.45 $1,217,848
Sale
Common Stock 28,689 $42.45 $1,217,848
Option
Option to Purchase Common Stock 28,689 $11.29 $323,899
Sale
Common Stock 18,324 $45.91 $841,200
Option
Common Stock 8,803 N/A N/A
Option
Restricted Stock Units 8,803 N/A N/A
Option
Restricted Stock Units 5,771 N/A N/A
Option
Common Stock 5,771 N/A N/A
Option
Common Stock 7,883 N/A N/A
Option
Restricted Stock Units 7,883 N/A N/A
Option
Restricted Stock Units 8,134 N/A N/A
Option
Common Stock 8,134 N/A N/A
Sale
Common Stock 12,000 $42.9 $514,764
Sale
Common Stock 12,000 $38.64 $463,680
Sale
Common Stock 12,000 $30.43 $365,148
Sale
Common Stock 12,000 N/A N/A
Sale
Common Stock 12,000 N/A N/A
Sale
Common Stock 12,000 N/A N/A
Option
Option to Purchase Common Stock 18,613 N/A N/A
Option
Common Stock 18,613 N/A N/A
Option
Option to Purchase Common Stock 21,387 N/A N/A
Sale
Common Stock 21,387 N/A N/A
Option
Common Stock 21,387 N/A N/A
Option
Restricted Stock Units 8,803 N/A N/A
Option
Common Stock 8,803 N/A N/A
Option
Restricted Stock Units 5,772 N/A N/A
Option
Common Stock 5,772 N/A N/A
Option
Restricted Stock Units 7,883 N/A N/A
Option
Common Stock 7,883 N/A N/A
Option
Common Stock 23,118 N/A N/A